MedTrace Logo

Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Indies

NCT07576374 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2026-05-08

No results posted yet for this study

Summary

Genetics variants could be involved in atypical non-autoimmune diabetes revealed by ketoacidosis. The objective of this research will be to determine the relationships between the genetic variants already described in known monogenic diabetes or identified as involved in glucose metabolism and its regulation, in insulin signaling pathways or in insulin secretion itself in subjects of African and Indian ancestry with atypical forms of non autoimmune diabetes.

Conditions

  • Metabolic Diseases
  • Diabetes Mellitus (Type 2)
  • Genetic Variation
  • Genetic Profile
  • Glucose Metabolism Disorders

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de la Guadeloupe

    lead OTHER

Principal Investigators

  • Fritz-Line VELAYOUDOM, Doctor · CHU de la Guadeloupe

Eligibility

Min Age
18 Years
Max Age
47 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2029-09-30
Completion
2029-09-30

Countries

  • Guadeloupe

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07576374 on ClinicalTrials.gov